Revance Therapeutics Market Cap

TYO:5202 has a market cap or net worth of 48.29 billion as of August 1, 2025. Its market cap has increased by 27.31% in one year.

Market Cap

48.29B

Enterprise Value

541.33B

Revenue

840.40B

Ranking

n/a

PE Ratio

n/a

Stock Price

$522.00

Market Cap Chart

Since January 16, 1992, TYO:5202's market cap has decreased from 251.81B to 48.29B, a decrease of -80.82%. That is a compound annual growth rate of -4.80%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	48.29B	47.84%
Dec 30, 2024	32.66B	-37.73%
Dec 29, 2023	52.46B	1.49%
Dec 30, 2022	51.68B	10.79%
Dec 30, 2021	46.65B	8.21%
Dec 30, 2020	43.11B	-31.62%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Toyota Motor	35.14T
Fast Retailing	14.19T
Honda Motor	6,494.04B
DENSO	5,660.81B
Oriental Land	5,039.12B
Toyota Industries	4,890.23B
Aeon Co., Ltd.	4,156.13B
Bridgestone	4,118.96B

Market Cap Rankings